PND51 Cladribine Tablets (CT) Versus Other Disease-Modifying Therapies in the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) - Cost-Effectiveness Analysis.

Authors
Category Primary study
JournalValue in Health
Year 2020
This article has no abstract
Epistemonikos ID: 66faf76db08644e7d7a649e7e46e6b8f652cf8cc
First added on: Feb 12, 2025